You might also like
September is Childhood Cancer Awareness Month. 30,000 children in India and 10 times that number worldwide develop cancer every year. There is a lack of awareness and timely diagnosis to treat them. Sapien will be sharing the Indian cancer data it has throughout September, starting with colorectal cancer.
Sapien’s samples and real world data enables validation of a new Indian breast cancer test with high concordance to OncotypeDx test
Sree Voleti of BioNest and UoH in a wide-ranging frank monsoon chat with Jugnu on why she chose to return to India, why an entrepreneur, why Sapien, why Apollo, why Hyderabad …. on the road less travelled
Lymphomas are cancers that develop in the lymphatic system. Typical symptoms start with fever, swelling of some lymph nodes, weight loss, tiredness. The affected lymph nodes could be in the neck, armpit, groin, tonsils, stomach, small intestine. Once a cancer begins in one part of the lymphatic system, it can spread rapidly to other lymph nodes so early diagnosis is important. Diagnosis is done by PET or CT scan and/or biopsy, as suggested by a doctor. The incidence of lymphomas is ~5-7% among all childhood cancers. It is 2-3 time more common in boys than in girls. In India, lymphoma was reported to be the 2nd most common cancer in young boys.
Validating herbal, natural products and drug candidates in cancer patient cells to design optimal clinical trials.
The largest category of breast cancers are hormone receptor (HR) positive. These comprise 55-60% of all breast cancers globally as well as in India. Unlike triple negative breast cancer (TNBC), HR positive breast cancers respond well to personalized treatment with newer drugs and have a high chance of successful treatment and long-term survival even in advanced stages. Hence it is important to get them diagnosed and typed for HR positivity early on and tailor the treatment for each patient.
1st Floor, AIMSR Building,
Apollo Health City,
Hyderabad 500 096
- Our paper is out in Frontiers in Pharmacology
- Sapien’s work for Hillstream BioPharma presented at AACR
- Dr. Jugnu Jain shares her thoughts on entrepreneurship with the T-Hub Hyderabad
- Landscape of Kinase gene fusions in cancers
- ALK targeted therapy for lung cancer: Integration of NGS genome profiling in management of ALK-mutated NSCLCs in India